DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-47 Cr | ₹726 Cr | ₹139 Cr | ₹-936 Cr | ₹-70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DR REDDYS LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-47 Cr |
| Mar2025 | ₹726 Cr |
| Mar2024 | ₹139 Cr |
| Mar2023 | ₹-936 Cr |
| Mar2022 | ₹-70 Cr |
How is Net Cash Inflow / Outflow of DR REDDYS LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-47 Cr | Negative | |
| Mar2025 | ₹726 Cr | 423.58 | |
| Mar2024 | ₹139 Cr | Positive | |
| Mar2023 | ₹-936 Cr | Negative | |
| Mar2022 | ₹-70 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹97,242.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| MANKIND PHARMA | ₹99,077.7 Cr | 0.5% | -7.4% | -7.3% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -1.4% |
2.9% |
-8% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses